2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation

被引:54
作者
Chao, Tze-Fan [1 ,2 ,3 ]
Joung, Boyoung [4 ]
Takahashi, Yoshihide [5 ]
Lim, Toon Wei [6 ]
Choi, Eue-Keun [7 ]
Chan, Yi-Hsin [8 ,9 ]
Guo, Yutao [10 ]
Sriratanasathavorn, Charn [11 ]
Oh, Seil [7 ]
Okumura, Ken [12 ]
Lip, Gregory Y. H. [13 ,14 ,15 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, 201,Sec 2,Shih Pai Rd, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[4] Yonsei Univ, Dept Internal Med, Div Cardiol, Coll Med, Seoul, South Korea
[5] Tokyo Med & Dent Univ, Dept Adv Arrhythmia Res, Tokyo, Japan
[6] Natl Univ Singapore Hosp, Natl Univ Heart Ctr, Singapore, Singapore
[7] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[8] Chang Gung Mem Hosp, Microscopy Core Lab, Taoyuan, Taiwan
[9] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[10] Chinese Peoples Liberat Army Gen Hosp, Pulm Vessel & Thrombot Dis, Beijing, Peoples R China
[11] Her Majesty Cardiac Ctr, Siriraj, Thailand
[12] Saiseikai Kumamoto Hosp, Div Cardiol, Kumamoto, Japan
[13] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[14] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[15] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
关键词
APHRS; atrial fibrillation; consensus guidelines; stroke prevention; ANTAGONIST ORAL ANTICOAGULANTS; TRANSIENT ISCHEMIC ATTACK; CARDIAC-ARRHYTHMIA SOCIETY; MOBILE HEALTH TECHNOLOGY; BLEEDING RISK-ASSESSMENT; CARDIOLOGY WORKING GROUP; VITAMIN-K ANTAGONISTS; SOUTHERN AFRICA CASSA; AF-TIMI; 48; APPENDAGE CLOSURE;
D O I
10.1002/joa3.12652
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in Asia-Pacific region. In these years, many important new data regarding stroke prevention in AF were reported. The Practice Guidelines subcommittee members comprehensively reviewed updated information on stroke prevention in AF, and summarized them in this 2021 focused update of the 2017 consensus guidelines of the APHRS on stroke prevention in AF. We highlighted and focused on several issues, including the importance of AF Better Care (ABC) pathway, the advantages of non-vitamin K antagonist oral anticoagulants (NOACs) for Asians, the considerations of use of NOACs for Asian patients with AF with single 1 stroke risk factor beyond gender, the role of lifestyle factors on stroke risk, the use of oral anticoagulants during the "coronavirus disease 2019" (COVID-19) pandemic, etc. We fully realize that there are gaps, unaddressed questions, and many areas of uncertainty and debate in the current knowledge of AF, and the physician's decision remains the most important factor in the management of AF.
引用
收藏
页码:1389 / 1426
页数:38
相关论文
共 318 条
  • [71] Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study
    Choi, You-jung
    Han, Kyung-do
    Choi, Eue-Keun
    Jung, Jin-Hyeung
    Lee, So-Ryoung
    Oh, Seil
    Lip, Gregory Y. H.
    [J]. DIABETES CARE, 2021, 44 (06) : 1393 - 1401
  • [72] Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study
    Choi, You-Jung
    Choi, Eue-Keun
    Han, Kyung-Do
    Jung, Jin-Hyung
    Park, Jiesuck
    Lee, Euijae
    Choe, Wonseok
    Lee, So-Ryoung
    Cha, Myung-Jin
    Lim, Woo-Hyun
    Oh, Seil
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 130 - 135
  • [73] Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis
    Chokesuwattanaskul, Ronpichai
    Thongprayoon, Charat
    Tanawuttiwat, Tanyanan
    Kaewput, Wisit
    Pachariyanon, Pavida
    Cheungpasitporn, Wisit
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (07): : 878 - 878
  • [74] Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoina Hemodialysis
    Coleman, Craig, I
    Kreutz, Reinhold
    Sood, Nitesh A.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Baker, William L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2019, 132 (09) : 1078 - 1083
  • [75] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
    Connolly, S.
    Pogue, J.
    Hart, R.
    Pfeffer, M.
    Hohnloser, S.
    Chrolavicius, S.
    Yusuf, S.
    [J]. LANCET, 2006, 367 (9526) : 1903 - 1912
  • [76] Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
    Connolly, S. J.
    Crowther, M.
    Eikelboom, J. W.
    Gibson, C. M.
    Curnutte, J. T.
    Lawrence, J. H.
    Yue, P.
    Bronson, M. D.
    Lu, G.
    Conley, P. B.
    Verhamme, P.
    Schmidt, J.
    Middeldorp, S.
    Cohen, A. T.
    Beyer-Westendorf, J.
    Albaladejo, P.
    Lopez-Sendon, J.
    Demchuk, A. M.
    Pallin, D. J.
    Concha, M.
    Goodman, S.
    Leeds, J.
    Souza, S.
    Siegal, D. M.
    Zotova, E.
    Meeks, B.
    Ahmad, S.
    Nakamya, J.
    Milling, T. J., Jr.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (14) : 1326 - 1335
  • [77] Apixaban in Patients with Atrial Fibrillation
    Connolly, Stuart J.
    Eikelboom, John
    Joyner, Campbell
    Diener, Hans-Christoph
    Hart, Robert
    Golitsyn, Sergey
    Flaker, Greg
    Avezum, Alvaro
    Hohnloser, Stefan H.
    Diaz, Rafael
    Talajic, Mario
    Zhu, Jun
    Pais, Prem
    Budaj, Andrzej
    Parkhomenko, Alexander
    Jansky, Petr
    Commerford, Patrick
    Tan, Ru San
    Sim, Kui-Hian
    Lewis, Basil S.
    Van Mieghem, Walter
    Lip, Gregory Y. H.
    Kim, Jae Hyung
    Lanas-Zanetti, Fernando
    Gonzalez-Hermosillo, Antonio
    Dans, Antonio L.
    Munawar, Muhammad
    O'Donnell, Martin
    Lawrence, John
    Lewis, Gayle
    Afzal, Rizwan
    Yusuf, Salim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) : 806 - 817
  • [78] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [79] Dalal Jamshed, 2015, Indian Heart J, V67 Suppl 2, pS13, DOI 10.1016/j.ihj.2015.10.380
  • [80] The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight-a systematic literature review
    De Caterina, Raffaele
    Lip, Gregory Y. H.
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (08) : 565 - 572